Ciclesonide Inhaler Treatment for Mild-to-Moderate COVID-19: A Randomized, Open-Label, Phase 2 Trial
Journal of Clinical Medicine (2021) - Comments
doi: 10.3390/jcm10163545  issn: 2077-0383  pubmed: 34441840 

Joon-Young Song, Jin-Gu Yoon, Yu-Bin Seo, Jacob Lee, Joong-Sik Eom, Jin-Soo Lee, Won-Suk Choi, Eun-Young Lee, Young-Ah Choi, Hak-Jun Hyun, Hye Seong, Ji-Yun Noh, Hee-Jin Cheong, Woo-Joo Kim